Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal Fourth Quarter and Full Year 2001 Earnings

Apr 18, 2001, 01:00 ET from Forest Laboratories, Inc.

    NEW YORK, April 18 /PRNewswire/ -- Forest Laboratories, Inc. (NYSE:   FRX)
 will release its fiscal fourth quarter and full year 2001 financial results
 before the market opens on Tuesday, April 24, 2001.  Later that morning, at
 10:00AM EDT, Forest will host a conference call to discuss the results.  The
 conference call will be webcast live beginning at 10:00AM EDT on the Company's
 website http://www.frx.com and also on the website
 http://www.streetevents.com.  Please log on to either website at least fifteen
 minutes prior to the conference call as it may be necessary to download
 software to access the call.  A replay of the conference call will be
 available until May 8, 2001 at both websites and also by dialing
 1 800 642 1687 (US investors) or +1 706 645 9291 (international investors)
 passcode #716780.
     (Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )
     Forest Laboratories, Inc. is a New York, NY based pharmaceutical company
 which currently markets Celexa (TM) (citalopram HBr), which is available for
 the treatment of depression, Tiazac(R), a once-daily diltiazem, which is
 indicated for the treatment of angina and hypertension and Aerobid(R), an
 inhaled steroid indicated for the treatment of asthma.  Foerst is developing a
 growing portfolio of pharmaceutical products which includes: escitalopram for
 depression, Flunisolide HFA for the treatment of asthma, memantine for
 Alzheimer's disease and neuropathic pain, lercanidipine for hypertension,
 ML3000 for osteoarthritis, dexloxiglumide for irritable bowel syndrome,
 siramesine for anxiety and ALX-0646 for migraine headache.
 
 

SOURCE Forest Laboratories, Inc.
    NEW YORK, April 18 /PRNewswire/ -- Forest Laboratories, Inc. (NYSE:   FRX)
 will release its fiscal fourth quarter and full year 2001 financial results
 before the market opens on Tuesday, April 24, 2001.  Later that morning, at
 10:00AM EDT, Forest will host a conference call to discuss the results.  The
 conference call will be webcast live beginning at 10:00AM EDT on the Company's
 website http://www.frx.com and also on the website
 http://www.streetevents.com.  Please log on to either website at least fifteen
 minutes prior to the conference call as it may be necessary to download
 software to access the call.  A replay of the conference call will be
 available until May 8, 2001 at both websites and also by dialing
 1 800 642 1687 (US investors) or +1 706 645 9291 (international investors)
 passcode #716780.
     (Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )
     Forest Laboratories, Inc. is a New York, NY based pharmaceutical company
 which currently markets Celexa (TM) (citalopram HBr), which is available for
 the treatment of depression, Tiazac(R), a once-daily diltiazem, which is
 indicated for the treatment of angina and hypertension and Aerobid(R), an
 inhaled steroid indicated for the treatment of asthma.  Foerst is developing a
 growing portfolio of pharmaceutical products which includes: escitalopram for
 depression, Flunisolide HFA for the treatment of asthma, memantine for
 Alzheimer's disease and neuropathic pain, lercanidipine for hypertension,
 ML3000 for osteoarthritis, dexloxiglumide for irritable bowel syndrome,
 siramesine for anxiety and ALX-0646 for migraine headache.
 
 SOURCE  Forest Laboratories, Inc.